Vizient, Inc. Concerned that the CMS Outpatient Prospective Payment System (OPPS) Proposed Rule Could Harm Hospitals and Threaten Access to Care




IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. is disappointed with elements of the Centers for Medicare and Medicaid Services (CMS) annual outpatient prospective payment system proposed rule (OPPS). Among other policies, CMS has taken aim at vital safety net programs and proposed further slashing payment rates at some hospital outpatient departments.

Safety net hospitals, academic medical centers and other providers serving vulnerable patients are vitally important components of our health care community – they serve the most at-risk patients and their families. One proposed policy in the OPPS rule would reduce reimbursements for some services at new off-campus provider-based departments by 25 percent. As hospitals are being urged to move patient care into the outpatient setting, a policy that cuts reimbursements for these services has the negative consequence of creating the opposite incentive. This threatens access to care, especially in rural areas that may have fewer sites of service.

Another proposal that would further threaten access to care is a policy which impacts the 340B Drug Discount Program, a critical safety net program. 340B hospitals provide vital health care services to the nation’s most vulnerable populations, and the 340B program is critically important to increasing access to costly prescription drugs for these patient populations. CMS is proposing a drastic reduction in Medicare reimbursement for 340B drugs, which will have a severe and negative impact on safety net hospitals and the patients they serve. Reducing 340B hospital reimbursements will do nothing to address the rising cost of prescription drugs and will only threaten access to care.

We urge CMS to reconsider these harmful proposals and look forward to working with the agency on policies that will increase efficiencies, enhance quality of care, and protect patient access to life-saving medication.

Vizient is the nation’s largest health care performance improvement company serving a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health care delivery networks and non-acute health care providers.

About Vizient, Inc.

Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as MedAssets’ Spend and Clinical Resource Management (SCM) segment, including Sg2, which was acquired in 2016. In 2017, Vizient again received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient’s headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit as well as our newsroom, blog, Twitter, LinkedIn and YouTube pages for more information about the company.


Vizient, Inc.
Angie Boliver, 972-830-7961

Related Materials